STOCK TITAN

atai Life Sciences to Participate in the Jefferies 2024 Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

atai Life Sciences (NASDAQ: ATAI), a clinical-stage biopharmaceutical company focused on mental health disorders, announced its participation in the Jefferies Global Healthcare Conference from June 4-6, 2024. The company will engage in a fireside chat on June 6 at 10:00 A.M. ET in New York. The live webcast will be accessible on the company's investor relations page, with a replay available post-event.

Positive
  • Participation in a prominent industry conference, indicating active engagement and visibility in the healthcare sector.
  • Opportunity to showcase their progress and strategies to a broad audience, potentially attracting new investors.
  • Availability of a live webcast and replay enhances transparency and investor relations.
Negative
  • No new financial or clinical data presented, providing new insights for investors.
  • Announcement of participation without specific details on what will be discussed might not generate significant investor interest.

NEW YORK and BERLIN, May 31, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that the Company’s management team will participate in the Jefferies Global Healthcare Conference being held from June 4-6, 2024.

Details of the company’s participation:

Format: Fireside Chat
Date and Time: Thursday June 6 at 10:00 A.M. ET
Location: New York
Webcast link: here

The live webcast of the fireside chat will also be available on the Investors section of the atai website under Events. A replay will be available following the live event.

About atai Life Sciences

atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders and was founded as a response to the significant unmet need and lack of innovation in the mental health treatment landscape. atai is dedicated to efficiently developing innovative therapeutics to treat depression, anxiety, addiction, and other mental health disorders. By pooling resources and best practices, atai aims to responsibly accelerate the development of new medicines to achieve clinically meaningful and sustained behavioral change in mental health patients. atai's vision is to heal mental health disorders so that everyone, everywhere can live a more fulfilled life. For more information, please visit www.atai.life.

Contact Information

Investor Contact:

IR@atai.life

Media Contact:

PR@atai.life


FAQ

What is the date and time of atai Life Sciences' participation in the Jefferies Global Healthcare Conference?

atai Life Sciences will participate in a fireside chat on June 6, 2024, at 10:00 A.M. ET.

Where can I watch the atai Life Sciences fireside chat at the Jefferies Global Healthcare Conference?

The fireside chat will be live-streamed on the atai Life Sciences investor relations page, with a replay available after the event.

What is the focus of atai Life Sciences?

atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders.

What is the stock symbol for atai Life Sciences?

The stock symbol for atai Life Sciences is ATAI.

ATAI Life Sciences N.V. Common Shares

NASDAQ:ATAI

ATAI Rankings

ATAI Latest News

ATAI Stock Data

182.90M
167.80M
9.99%
27.11%
5.72%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BERLIN